Rouan Sarah Kathryn 4
4 · Viking Therapeutics, Inc. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Rouan Sarah Kathryn
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-01-03+22,000→ 22,000 totalExercise: $4.88From: 2023-01-03Exp: 2032-01-03→ Common Stock (22,000 underlying)